Immunotherapy in managing metastatic melanoma : which treatment when?

Amaral, Teresa; Meraz-Torres, Francisco; Garbe, Claus

dc.contributor.author	Amaral, Teresa
dc.contributor.author	Meraz Torres, Francisco
dc.contributor.author	Garbe, Claus
dc.date.accessioned	2019-05-28T13:42:35Z
dc.date.available	2019-05-28T13:42:35Z
dc.date.issued	2017
dc.identifier.issn	1744-7682
dc.identifier.uri	http://hdl.handle.net/10900/89034
dc.language.iso	en	de_DE
dc.publisher	Taylor & Francis Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1080/14712598.2017.1378640	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Immunotherapy in managing metastatic melanoma : which treatment when?	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190131163842_04243
utue.publikation.seiten	1523-1538	de_DE
utue.personen.roh	Amaral, Teresa
utue.personen.roh	Meraz-Torres, Francisco
utue.personen.roh	Garbe, Claus
dcterms.isPartOf.ZSTitelID	Expert Opinion on Biological Therapy	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	17	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE